NCT07076056CompletedPhase 3
Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2
A Randomized, Double-blind, Multi-center, Placebo-controlled, Phase III Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2 Add-on to Metformin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Sitagliptin Combination Therapy
Source: ClinicalTrials.gov · Last updated 21 Jul 2025
Brief summary (registry, in English)
A Randomized, Double-blind, Multi-center, Placebo-controlled, Phase III Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2 Add-on to Metformin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Sitagliptin Combination Therapy
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 230 (actual)
- First submitted
- 13 Jul 2025
- Start date
- 27 Oct 2022
- Primary completion date
- 4 Dec 2023
- Lead sponsor
- Daewon Pharmaceutical Co., Ltd.
- Diseases
- Type 2 diabetes
- NCT number
- NCT07076056
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 230
- From 27 Oct 2022 to the primary completion date, 4 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a history of diagnosis of malignant tumors within 5 years prior to visit 1
Other illness
- Patients with a history of acute pancreatitis
- Patients with a history of pre-diabetic coma
Who the study is looking for
- Patients who are diagnosed with Type2 Diabetes
- 19 ≤ Age ≤ 85
- 7.0% ≤ HbA1c ≤ 10.5%
Age in the registry: 19 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yeouido St. Mary's Hospital The Catholic University Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.